The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer
- 1 May 1993
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 67 (5) , 1132-1135
- https://doi.org/10.1038/bjc.1993.208
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9British Journal of Cancer, 1992
- The Tumour Marker CA 195 in Colorectal and Pancreatic CancerThe International Journal of Biological Markers, 1991
- Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinoma.1990
- PROSPECTIVE MONITORING TRIAL FOR CARCINOMA OF COLON AND RECTUM AFTER SURGICAL RESECTION1989
- Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group.Journal of Clinical Oncology, 1989
- Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer.Gut, 1987
- The Value of CA 19–9 in Gastric and Colorectal CarcinomaCancer Investigation, 1987
- Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancerThe American Journal of Surgery, 1985